Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

Thomas Hope

Status

Conditions: Parathyroid Adenomas

Treatments: Drug: 18F-Fluorocholine (FCH); Procedure: Positron emission tomography (PET)

Study type: Expanded Access

Funder types: Other

Identifiers

NCT07218224

25-44398

Details and patient eligibility

About

This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.

Full description

No health outcome measures will be obtained under this protocol.

Sex: All

Ages: 13+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥ 13 years.
2. Evidence of primary hyperparathyroidism.
3. Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion criteria

1. Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation.